Banner for leaf pages 2

Ramelteon (Rozerem)

Also known as Rozerem

Ramelteon, marketed as Rozerem by Takeda Pharmaceuticals North America, is the first in a new class of sleep agents that selectively binds to the MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), instead of binding to GABA A receptors, such as with drugs like zolpidem, eszopiclone, and zaleplon. Ramelteon is approved by the U.S. Food and Drug Administration (FDA) for long-term use.

Source: Wikipedia

Estimated Total Cost: $128.16 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed ramelteon to treat depression, bipolar disorder, insomnia, and personality disorder.

What side effects are related?

Patients taking ramelteon most commonly experience side effects like fatigue, nausea, and insomnia.

Ajax-loader Loading...